Breast Reconstruction News and Research

RSS

Caprini Risk Model helps predict VTE risk in patients undergoing plastic surgery

Patients undergoing plastic or reconstructive surgery should receive a risk assessment before their procedure to predict whether they'll develop potentially fatal blood clots in the legs or lungs, according to research at the University of Michigan Medical School. Researchers also found that 1 in 9 patients at highest risk based on that assessment will develop clots if not given clot-preventing medications after surgery.

19 Nov 2010

National Conference to educate breast cancer patients about personal health

Leading breast cancer experts and survivors will present at this weekend's Body, Mind, Spirit 2010: National Conference for Young Women Living with Breast Cancer. Presented by the Canadian Breast Cancer Network and co-presenter the Canadian Breast Cancer Foundation, this conference hosts young women with breast cancer to educate them in all aspects of their cancer journey.

30 Oct 2010

Advanced procedure for microsurgical breast reconstruction offered at Baptist Health hospitals

When pediatrician Julie A. Buckley, MD, learned that she had breast cancer last year, she chose breast reconstruction using the “DIEP flap” procedure. DIEP (Deep Inferior Epigastric Artery Perforator) flap is available mainly at regional academic centers in the United States.

27 Oct 2010

Stem cell-enriched autologous fat treatment safe for breast reconstruction after cancer surgery

Since 2003, breast augmentation utilizing stem cells from autologous fat has been developed enabling silicon-free breast reconstruction following cancer surgery. Till now though, it was unclear whether this might reactivate the cancer again. However, University of Pittsburgh researchers led by Prof. Albert Donnenberg have now demonstrated that stem cell-enriched autologous fat is safe even in the presence of inactive tumor cells.

13 Oct 2010

Study shows Strattice TM is safe for single-stage hernia repair

Kinetic Concepts, Inc. today announced that its LifeCell Strattice Reconstructive Tissue Matrix achieved highly favorable one-year outcomes in an ongoing clinical study of single-stage repair of contaminated or infected ventral incisional hernias.

6 Oct 2010

Gore launches larger sized BIO-A Tissue Reinforcement for surgical procedures

W. L. Gore & Associates (Gore) today announced the availability of larger sized GORE® BIO-A® Tissue Reinforcement, a valuable alternative to biologics for reinforcement of soft tissue in surgical procedures. GORE BIO-A Tissue Reinforcement is a unique non-biologic scaffold that is gradually absorbed by the body. The open, highly interconnected 3D pore structure facilitates rapid cell infiltration and vascularization.

5 Oct 2010

Fat-derived stem cells can aid breast reconstruction after mastectomy

Fat-derived stem cells can be safely used to aid reconstruction of breast tissue after mastectomy as long as there is no evidence of active cancer, according to researchers at the University of Pittsburgh School of Medicine.

17 Sep 2010

Lippincott Williams & Wilkins enter into licensing agreement with CJAPS to provide PRS journal in Chinese

Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, is pleased to announce that it has entered into a licensing agreement with the Chinese Journal of Aesthetic and Plastic Surgery (CJAPS), to provide selected articles and abstracts from Plastic and Reconstructive Surgery (PRS), the official journal of the American Society of Plastic Surgeons, to be translated into Chinese and published in CJAPS.

15 Sep 2010

NUH receives DSRB approval for new comparative study with TIGR Matrix Surgical Mesh

Novus Scientific Pte. Ltd today announced that the National University Hospital (NUH), Singapore has received Domain Specific Review Board (DSRB i.e. IRB equivalent) provisional approval for a new study: Abdominal Wall Closure After Lipectomy, TRAM/DIEP Flap - Comparison of TIGR (100% Resorbable) vs Polypropylene (Permanent) Mesh.

13 Sep 2010

Consultation with plastic surgeon impacts decision to perform breast reconstruction: Study

When breast cancer surgeons regularly confer with plastic surgeons prior to surgery, their patients are more likely to have reconstruction, according to a new study led by researchers at the University of Michigan Comprehensive Cancer Center.

3 Sep 2010

LifeCell, Novadaq Technologies sign exclusive sales, marketing agreement

LifeCell Corporation, a business unit of Kinetic Concepts, Inc., and Novadaq Technologies Inc. announced today the signing of an exclusive sales and marketing agreement for distribution of Novadaq's SPY Imaging System in North American surgical markets. LifeCell will drive adoption for the SPY System in breast reconstructive, head and neck, and colorectal surgical specialties, with more than half a million procedures projected annually.

2 Sep 2010

Hospitals should inform patients about availability of insurance coverage for breast reconstruction: New law

While breast reconstruction after a mastectomy is covered by insurers in New York, many poor, minority, and less educated women do not seek out the procedure. Now, NY Gov. David A. Paterson has signed into law a bill that is aimed at reversing this trend.

18 Aug 2010

Safeguard Scientifics second-quarter aggregate revenue of partner companies increase 47% to $91.6 million

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the three months ended June 30, 2010 was $91.6 million, up 47% from $62.3 million for the same partner companies in the same period of 2009. For the six months ended June 30, 2010, the aggregate partner company revenue was $176.9 million, up 45% from $121.8 million for the same partner companies for the same period of 2009.

29 Jul 2010

Cytori Therapeutics receives European approval for Celution System

Cytori Therapeutics received expanded European approval (CE Mark) for its Celution System, a medical device that extracts and separates stem and regenerative cells from a patient's own fat tissue. The new indications include key medical applications such as breast reconstruction, repair of soft tissue defects, as well as the facilitation of healing certain types of wounds, such as those resulting from Crohn's disease. This broadens Cytori's ability to offer the Celution System to patients and hospitals and further supports the company's efforts to gain treatment reimbursement.

28 Jul 2010

BioDigital, NYU Langone partner to create Right Upper Lobe Resection Cognitive Task Trainer

SensAble Technologies, a leader in haptic devices and 3D modeling solutions, announced that its customer, BioDigital, working in partnership with surgeons at NYU Langone Medical Center, has created the first medical simulation application for teaching residents the high-technology procedure for lung resection of the right upper lobe, most commonly performed to treat resectable lung cancers.

23 Jun 2010

Encouraging interim results from stem and regenerative cell-enriched fat grafting breast reconstruction trial

Interim results from a breast reconstruction trial show stem and regenerative cell-enriched fat grafting resulted in a high sustained rate of physician and patient satisfaction and persistent improvements in overall outcomes of the procedure at six and 12 months.

18 Jun 2010

Nineteen facilities named Centers of Excellence in APBI for use of SAVI applicator

Nineteen facilities in the Mid-Atlantic region have been named Centers of Excellence in accelerated partial breast irradiation for their use of the SAVI applicator, an advanced therapy for breast cancer as part of breast conservation therapy. The SAVI applicator can provide important advantages for women with early-stage breast cancer.

17 Jun 2010

Ashikari Breast Center to participate in TARGiT intra-operative radiotherapy trial

The Ashikari Breast Center at The Dobbs Ferry Pavilion of St. John's Riverside Hospital today announced its participation in two new groundbreaking studies that may alter the care for early breast cancer.

11 Jun 2010

22 Midwest facilities named Centers of Excellence in accelerated partial breast irradiation

Twenty-two facilities in the Midwest have been named Centers of Excellence in accelerated partial breast irradiation (APBI) for their use of the SAVI® applicator, an advanced therapy for breast cancer as part of breast conservation therapy. The SAVI applicator can provide important advantages for women with early-stage breast cancer.

10 Jun 2010

Low frequency ultrasound can heal and regenerate body tissues

When we think of ultrasound, it's usually imaging the inside of the body that springs to mind. However, while ultrasound imaging typically requires frequencies that are 50 to 2500 times higher than those human ear can detect, recent increasing evidence indicates that ultrasound at lower frequency can also be used to help certain body tissues to heal and regenerate. Now research that appears in Open Access Journal of Tissue Engineering published by SAGE-Hindawi suggests that ultrasound could also help tissue grafts to survive and thrive following surgery.

28 May 2010